ScinoPharm Taiwan Ltd. | Income Statement
Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,088
4,098
3,955
4,031
3,516
3,524
Cost of Goods Sold (COGS) incl. D&A
2,644
2,613
2,393
2,338
2,103
2,105
Gross Income
2,444
1,485
1,562
1,693
1,414
1,419
SG&A Expense
1,047
926
812
824
854
861
EBIT
1,398
559
750
868
559
558
Unusual Expense
9
21
11
3
15
16
Non Operating Income/Expense
7
51
42
52
47
5
Interest Expense
8
4
9
36
77
80
Pretax Income
1,425
618
802
811
475
491
Income Tax
135
118
168
152
53
48
Equity in Affiliates
17
15
1
-
-
-
Consolidated Net Income
1,273
484
635
659
422
443
Net Income
1,273
484
635
659
422
443
Net Income After Extraordinaries
1,273
484
635
659
422
443
Net Income Available to Common
1,273
484
635
659
422
443
EPS (Basic)
1.61
0.61
0.80
0.84
0.51
0.56
Basic Shares Outstanding
791
791
791
791
822
791
EPS (Diluted)
1.61
0.61
0.80
0.83
0.51
0.56
Diluted Shares Outstanding
791
791
792
794
824
793
EBITDA
1,845
1,031
1,232
1,313
992
964
Non-Operating Interest Income
38
32
31
28
25
33
About ScinoPharm Taiwan
View Profile
